For the latest updates and information in response to COVID-19, please click here.

About Nordimet®

Welcome to the Nordimet® online resource for UK healthcare professionals.

Here you can find out more about the Nordimet® methotrexate auto-injector PEN, including its benefits, its usability and ease of initiation. You can also access different support packs designed for healthcare professionals and patients, and download initiation support tools for your hospital.

Nordimet®: simply designed with patients in mind

Nordimet® is activated in 2 simple steps:




INJECT: Press the needle shield against
the skin. First click confirms start of injection.
Second click confirms end of injection.

A usability study* demonstrated2

of patients successfully injected Nordimet®
in a ‘worst-case’ environment**

of patients described the injection process
as simple

Double click mechanism helps ensure the complete dose has been injected, giving confidence and reassurance to you and your patients

Nordimet®: a range of indications and presentations

8 presentations, in 2.5mg increments from 7.5mg to 25mg

  • The dose should be reduced to the lowest possible
    effective maintenance dose, once the desired therapeutic
    result is achieved

  • The recommended initial dose is 7.5mg
    once weekly, administered subcutaneously

Nordimet® is indicated for the treatment of:3

  • Active rheumatoid arthritis (RA) in adult patients

  • Polyarthritic forms of severe, active juvenile idiopathic arthritis,
    when the response to NSAIDs has been inadequate

  • Severe recalcitrant disabling psoriasis, which is not adequately
    responsive to other forms of therapy such as phototherapy,
    PUVA and retinoids

  • Severe psoriatic arthritis in adult patients

*Study included 42 RA patients and nurses/carers. Usability was based on a questionnaire with an adjusted 5-point Likert scale, with positive answers to closed questions defined as, for example, ‘Very useful’, ‘Useful’ or ‘Yes’.

**Dimmed light, TV or radio on, and phone ringing.

  1. Nordimet® Patient Information Leaflet.
  2. Hudry C et al. Rheumatol Ther 2017;4(1):183-194.
  3. Nordimet® Summary of Product Characteristics.